HomeCompareERF vs MRK

ERF vs MRK: Dividend Comparison 2026

ERF yields 1.29% · MRK yields 2.81%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ERF wins by $3.49M in total portfolio value· pulled ahead in Year 4
10 years
ERF
ERF
● Live price
1.29%
Share price
$20.09
Annual div
$0.26
5Y div CAGR
91.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$3.55M
Annual income
$2,890,423.76
Full ERF calculator →
MRK
Merck & Co. Inc.
● Live price
2.81%
Share price
$118.10
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$57.7K
Annual income
$10,113.78
Full MRK calculator →

Portfolio growth — ERF vs MRK

📍 ERF pulled ahead of the other in Year 4

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodERFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ERF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ERF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ERF
Annual income on $10K today (after 15% tax)
$110.00/yr
After 10yr DRIP, annual income (after tax)
$2,456,860.20/yr
MRK
Annual income on $10K today (after 15% tax)
$238.95/yr
After 10yr DRIP, annual income (after tax)
$8,596.71/yr
At 15% tax rate, ERF beats the other by $2,448,263.48/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ERF + MRK for your $10,000?

ERF: 50%MRK: 50%
100% MRK50/50100% ERF
Portfolio after 10yr
$1.80M
Annual income
$1,450,268.77/yr
Blended yield
80.49%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

ERF
Analyst Ratings
11
Buy
9
Hold
Consensus: Buy
Price Target
$39.00
+94.1% upside vs current
Range: $39.00 — $39.00
Altman Z
5.0
Piotroski
6/9
MRK
Analyst Ratings
24
Buy
12
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+8.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ERF buys
0
MRK buys
8
PoliticianChamberTickerTypeAmountDate
Josh Gottheimer🏢 House$MRK▲ Buy$1,001 - $15,0002026-02-04
Michael McCaul🏢 House$MRK▼ Sell$15,001 - $50,0002026-01-13
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-12-19
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-12-18
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-11-13
Ro Khanna🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-29
Val Hoyle🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-23
Marjorie Taylor Greene🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-28
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-08-14
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-05
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricERFMRK
Forward yield1.29%2.81%
Annual dividend / share$0.26$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR91.7%32.7%
Portfolio after 10y$3.55M$57.7K
Annual income after 10y$2,890,423.76$10,113.78
Total dividends collected$3.47M$29.8K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusBuyBuy
Analyst price target$39.00$128.54

Year-by-year: ERF vs MRK ($10,000, DRIP)

YearERF PortfolioERF Income/yrMRK PortfolioMRK Income/yrGap
1$10,948$248.09$11,213$373.04$265.00MRK
2$12,201$486.62$12,667$512.06$466.00MRK
3$14,027$971.61$14,439$708.14$412.00MRK
4← crossover$17,010$2,001.19$16,640$988.16+$370.00ERF
5$22,548$4,347.79$19,432$1,394.07+$3.1KERF
6$34,452$10,325.74$23,057$1,992.90+$11.4KERF
7$65,130$28,266.07$27,889$2,894.79+$37.2KERF
8$165,423$95,733.97$34,518$4,286.29+$130.9KERF
9$612,634$435,630.96$43,912$6,494.35+$568.7KERF
10$3,545,942$2,890,423.76$57,714$10,113.78+$3.49MERF

ERF vs MRK: Complete Analysis 2026

ERFStock

Enerplus Corporation, together with subsidiaries, engages in the exploration and development of crude oil and natural gas in the United States and Canada. The company's oil and natural gas properties are located primarily in North Dakota, Colorado, and Pennsylvania; and Alberta, British Columbia, and Saskatchewan. As of December 31, 2021, it had proved plus probable gross reserves of approximately 8.2 million barrels (MMbbls) of light and medium crude oil; 20.7 MMbbls of heavy crude oil; 299.3 MMbbls of tight oil; 56.2 MMbbls of natural gas liquids; 19.7 billion cubic feet (Bcf) of conventional natural gas; and 1,367.9 Bcf of shale gas. Enerplus Corporation was founded in 1986 and is headquartered in Calgary, Canada.

Full ERF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this ERF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ERF vs SCHDERF vs JEPIERF vs OERF vs KOERF vs MAINERF vs JNJERF vs ABBVERF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.